Work

Potential Advantages of CUDC-101, a Multitargeted HDAC, EGFR, and HER2 Inhibitor, in Treating Drug Resistance and Preventing Cancer Cell Migration and Invasion

Year: 2013

Type: article

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.mct-12-1045

Authors: Jing Wang, Natalie W. Pursell, Maria Elena S. Samson, Ruzanna Atoyan, Anna W. Ma, Abdelkader Selmi, Wanlu Xu, Xiong Cai, Maurizio Voi, Pierre Savagner, Cheng-Jung Lai

Institutions: Inserm, Institut de Recherche en Cancérologie de Montpellier, Université Montpellier 1

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2164868034

FWCI: 4.466

Cites: 53

Cited by: 81

Related to: 10